Real-world study of adverse events associated with ceftazidime/avibactam based on the U.S. Food and Drug Administration adverse event reporting system database
The present study identified significant and novel AEs signals for CZA. Notably, the specific association between the CZA-meropenem combination and respiratory failure warrants vigilant clinical monitoring, distinct from general disease progression risks.
Authors
- Xin Zheng (ORCID: https://orcid.org/0000-0002-7327-0306)
- Yang-Xue Ou
- Peng Yang (ORCID: https://orcid.org/0000-0002-5935-0537)
- Yuan Cheng
- Lu Zhang
- Pu Xiang
- Mo Cheng
- Bi-bo You
Institutions
- People's Hospital of Kaizhou District (CN)
- Qujiang People's Hospital (CN)
- First People's Hospital of Chongqing (CN)
Publication Details
- Journal
- Frontiers in Cellular and Infection Microbiology
- Published
- 2026-01-22
- DOI
- https://doi.org/10.3389/fcimb.2026.1698293
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 0.00